A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
A non-randomized phase II study to determine the efficacy and safety of the combination of
Pemetrexed and Irinotecan every two weeks in metastatic colorectal cancer patients.